Skip to content

Exercise Training in Youth With Inflammatory Bowel Disease

The Effects of Exercise Training on Fitness, Function and Quality of Life in Youth With Inflammatory Bowel Disease: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05591976
Enrollment
11
Registered
2022-10-24
Start date
2013-05-01
Completion date
2014-06-01
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Inflammatory Bowel Diseases, Pediatric Crohns Disease, Pediatric Ulcerative Colitis

Brief summary

Children and adolescents with inflammatory bowel disease (IBD) suffer from many extra-intestinal side effects, including impaired muscle strength, low aerobic fitness, low bone density, and chronic inflammation. While exercise training can help remedy these issues in adults with IBD, no studies have examined the physiological effects of a structured aerobic and resistance exercise training intervention for youth with IBD. The aim of this pilot study is to to assess the feasibility, safety, and participant satisfaction of a structured 16-week training program for children with IBD. The secondary objectives of this study were to quantify the effects of a 16-week exercise training program on select physiological and behavioural outcomes in children with IBD.

Interventions

16-week, structured exercise training program including resistance and aerobic exercise

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* In remission (score of \>10) according to the pediatric Crohn's disease activity index (PCDAI) or the ulcerative colitis activity index (PUCAI) * Confirmed IBD diagnosis

Exclusion criteria

* Children who exercise train 3 times a week of more

Design outcomes

Primary

MeasureTime frameDescription
RecruitmentChange from baseline at 8 weeks and 1 week post interventionMeasure of patient recruitment (number of patients approached, enrolled, refused)
RetentionChange from baseline at 8 weeks and 1 week post interventionPercent of patients that completed the study after enrolment
AdherenceChange from baseline at 8 weeks and 1 week post interventionPercent of prescribed exercise completed across sessions
ComplianceChange from baseline at 8 weeks and 1 week post interventionPercent of exercise sessions completed
Changes in IBD-related symptoms: Pediatric Ulcerative Colitis Activity IndexChange from baseline at 8 weeks and 1 week post interventionTracking changes in IBD-related symptoms based on Pediatric Ulcerative Colitis Activity Index (scored 0-85, where higher score indicates more severe disease)
Changes in IBD-related symptoms: Pediatric Crohn's Disease Activity IndexChange from baseline at 8 weeks and 1 week post interventionTracking changes in IBD-related symptoms based on Pediatric Crohn's Disease Activity Index (scored 0-100, where higher score indicates more severe disease)
Qualitative assessment of participant likes and dislikes of the training program and suggestions for improvementChange from baseline at 8 weeks and 1 week post interventionAssessed by qualitative interview looking at likes and dislikes of the training program as well as suggestions for improvement
Tracking adverse eventsDuring training sessionAdverse events are event that occurs during the course of exercise training that cause the participant physical or psychological harm

Secondary

MeasureTime frameDescription
Body mass composition absolute valuesChange from baseline at 8 weeks and 1 week post interventionLean body mass (kg), fat body mass (kg), bone mineral content (kg), total mass (kg) all measured by Dual X-ray Absorptiometry scan
Inflammatory cytokine levelsChange from baseline at 8 weeks and 1 week post interventionIL-6 and TNF-alpha concentrations (pg/ml) measured from patient plasma by enzyme-linked immunosorbent assays
Body mass composition as a percent of total body massChange from baseline at 8 weeks and 1 week post interventionLean body mass (% of total mass), fat body mass (% of total mass), bone mineral content (% of total mass). Absolute body composition measures (kg) divided by total body mass (kg) make % of total mass. All measured by Dual X-ray Absorptiometry scan.
Bone mineral densityChange from baseline at 8 weeks and 1 week post interventionBone mineral density (g/cm\^3) measured by Dual X-ray Absorptiometry scan.
Aerobic fitness: maximum rate of oxygen consumption attainable during physical exertionChange from baseline at 8 weeks and 1 week post interventionVO2 peak (L\*min-1) measured by the McMaster All-Out Progressive Continuous Cycling Test using a calibrated metabolic cart
Aerobic fitness: peak workloadChange from baseline at 8 weeks and 1 week post interventionpeak workload (watts) measured by the McMaster All-Out Progressive Continuous Cycling Test using a cycle ergometer
Aerobic fitness: peak heart rateChange from baseline at 8 weeks and 1 week post interventionPeak heart rate (beats\*min-1), measured by the McMaster All-Out Progressive Continuous Cycling Test using heart rate monitor
Muscle strengthChange from baseline at 8 weeks and 1 week post interventionGrip strength (Nm), isokinetic and isometric leg strength (Nm) and isokinetic and isometric arm strength (Nm) all measured with an isokinetic dynamometer
Physical activity levelsChange from baseline at 8 weeks and 1 week post interventionTime spent in physical activity (at light, moderate and high intensity) and sedentary time (min\*day-1) measured by a waist-worn accelerometer

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026